Nathan Connell/LinkedIn
Sep 29, 2025, 04:51
Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
Vasculearn Network shared on LinkedIn:
”A major step forward for people living with hemophilia, and our very own Nathan Connell, MD, MPH, FACP, VLN Chair of Clinician Education, was one of the lead physicians behind this groundbreaking research.
A new gene therapy could reduce — or even eliminate — the need for regular infusions, giving patients more freedom in their daily lives.
This new approach delivers a functional gene to the liver, helping patients produce clotting factor IX—a protein that plays a critical role in the clotting process.
Watch the full CBS News segment here.”
Stay updated with Hemostasis Today.
-
Jan 10, 2026, 15:47Haematologica Journal Presents Review series on von Willebrand Disease
-
Jan 10, 2026, 15:15Stefan Gerner on Stroke Care and Subarachnoid Hemorrhage
-
Jan 10, 2026, 15:02Dr Manikanta Receives AHA Fellowship to Investigate Platelet-Dependent Nucleic Acid-Sensing Pathways
-
Jan 10, 2026, 14:40Last day at ASH25 from Riten Kumar
-
Jan 10, 2026, 08:56Shivanand Kumatagi Reflects on His Visit to Rela Hospital
-
Jan 10, 2026, 08:48Mitchell Elkind: Why Is The American Heart Association Holding a Brain Health Symposium?
-
Jan 10, 2026, 08:41Fiona Robinson Invites You to NBDF Webinar on Research Grants
-
Jan 10, 2026, 08:30Melissa Korn Takes Front Page Award for Her WSJ Piece on Experiencing a Pulmonary Embolism
-
Jan 10, 2026, 08:20Aymar Akilimali on Malaria in the Democratic Republic of Congo